drugset / Trial / NCT03356145

12 Versus 20 mL PCB for D&E Cervical Prep

NCT03356145 ↗

Phase 4 Completed 96 enrolled Stanford University
RandomizedParallel-groupSingle-blindTreatment

Summary

More research is needed to investigate methods of pain control for cervical preparation for abortion procedures. Women report pain with paracervical block injection as well as with osmotic dilator placement. This study seeks to compare a 12 mL, 2-site 1% plain lidocaine paracervical block for pain control during cervical preparation (osmotic dilator insertion) for Dilation and Evacuation (D\&E) to a 20 mL 1% lidocaine 2-site paracervical block.

Timeline

Start
2017-01-01
Primary completion
2020-10-15
Completion
2020-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 120 mg Other

Indications

No indication recorded.